M Me et th ho od ds s: : To investigate whether or not potassium channels play a role in the effect of volatile anesthetic on pulmonary vessels, isolated and perfused rabbit lungs were divided into four groups (n = 7 each): a control group without treatment, a glibenclamide (Glib) group treated with adenosine triphosphate-sensitive K + (K ATP ) channel inhibitor, a 4-aminopyridine (4-AP) group treated with voltage-sensitive K + (K V ) channel inhibitor, and an iberiotoxin (IbTX) group treated with high conductance calcium-activated K + (K Ca ) channel inhibitor. After inhibitor administration and stabilization, two minimum alveolar concentration (MAC) of halothane, enflurane, isoflurane, or 1.8 MAC of sevoflurane were randomly administered for 15 min followed by eight minutes of fresh gas mixture after each agent inhalation.
R Re es su ul lt ts s: : Isoflurane did not change pulmonary vascular tension in the control group but instead constricted the pulmonary vessels when K V channels were inhibited with 4-AP; constrictive effects of enflurane and halothane were observed on pulmonary vessels, and were enhanced by K V channel inhibition with 4-AP, but they were inhibited by K Ca channel inhibition with IbTX; the dilation effect of sevoflurane was observed on pulmonary vessels but was not significantly affected by any of the K + channel inhibitors.
C Co on nc cl lu us si io on n: : Halothane, enflurane and isoflurane, but not sevoflurane, regulate pulmonary vascular tension through K V and/or K Ca channels in isolated rabbit lungs. 1 The effects of volatile anesthetics on K V and K Ca K + channels located on pulmonary vessels remain largely unexplored. Some K + channel inhibitors have already been used clinically 2 and the activity of K + channels may change in certain pathophysiological conditions. 3 Therefore, it becomes clinically relevant to investigate if volatile anesthetics affect pulmonary vessels through K + channels. We have demonstrated previously that isoflurane (not sevoflurane) modulates pulmonary vascular response through K V and K Ca channels during hypoxia. 4 In the present study, we hypothesized that different inhaled anesthetics may affect pulmonary tension differently in the presence or absence of potassium channel inhibitors under normoxic conditions. The hypothesis was tested in isolated perfused rabbit lungs.
Objectif

M Ma at te er ri ia al ls s a an nd d m me et th ho od ds s Isolated lung preparation
The experimental protocol was approved by the Tottori University Faculty of Medicine Laboratory Animal Care Committee. Twenty-eight female Japanese white rabbits (2.0-2.5 kg) were anesthetized with pentobarbital (20 mg·kg -1 , intravenously) and ketamine (30 mg·kg -1 , intramuscularly). The lungs were isolated and perfused as described previously. 4, 5 Experimental protocol Following commencement of perfusion and ten minutes for stabilization, the lungs were divided into four groups in random order (n = 7, each) according to the K + channel subtype inhibitor added into the perfusate from the reservoir. In the control group, no channel inhibitor was added. In the glibenclamide (Glib) group, the perfusate contained 10 µM Glib, a highly selective K ATP channel inhibitor. In the iberiotoxin (IbTX) group, the perfusate contained 45 nM of IbTX, a highly selective inhibitor of K Ca channels. In the 4-aminopyridine (4-AP) group, the perfusate contained 1 mM of 4-AP, a K V channel inhibitor. Twenty minutes elapsed for stabilization after inhibitor administration, then two minimum alveolar concentrations (MAC) of halothane (2.8%), sevoflurane (7.4%), isoflurane (4.0%), or 1.8 MAC enflurane (5.3%) were randomly administered for 15 min. The lungs were ventilated without volatile agent for eight minutes to wash out the anesthetic after each agent inhalation and to allow the pulmonary vascular tension to return to the pre-inhalation value. Halothane, enflurane, isoflurane, or sevoflurane was administered using an agent specific vaporizer and monitored with an anesthetic gas monitor.
The pulmonary vascular resistance (PVR) was determined before and after each inhibitor or anesthetic administration. Total PVR (Rt), pulmonary arterial resistance (Ra) and pulmonary venous resistance (Rv) were determined as described previously. 4 Data are presented as mean ± SD. Within-group differences were analyzed using one-way analysis of variance (ANOVA) with repeated measures (Statview 4.5, Abacus Concepts, Berkeley, CA, USA). Pre-and post-agent administration comparison was performed with a t test. Multiple samples at the same time intervals were analyzed using one-way ANOVA. The differences in resistance among groups for each volatile anesthetic were analyzed with post hoc comparisons. Scheffe's test was used for post hoc comparisons. A P < 0.05 was considered significant.
R Re es su ul lt ts s Effects of K + channel inhibitors on PVR (Figure 1)
There was no significant difference in PVR among groups before K + channel inhibitor administration. PVR increased after 4-AP and IbTX administration, but did not change significantly after Glib administration.
Effects of volatile anesthetics on PVR in the absence of channel inhibitors
Pulmonary pressures and PVR returned to pre-inhalation values after washout of the volatile anesthetics. There was no significant difference in resistance before each anesthetic administration within the control group. Pulmonary vascular effects varied between volatile anesthetics. Enflurane and halothane significantly increased Ra and Rt. Sevoflurane decreased PVR. Isoflurane did not show any significant effect on PVR (Table I) .
The effect of volatile anesthetics on PVR in the presence of K
+ channel inhibitors Both halothane and enflurane constricted pulmonary vessels in the presence of 4-AP, IbTX, or Glib; isoflurane constricted pulmonary vessels only in the prescence of 4-AP; sevoflurane dilated pulmonary vessels in the presence of all the investigated channel inhibitors (Table II) . The absolute increase in resistance with halothane was augmented by 4-AP, inhibited by IbTX, but not significantly affected by Glib. The absolute increase in resistance with enflurane was enhanced by 4-AP, but not affected by IbTX or Glib. Isoflurane constricted the pulmonary vessels only when K V channels were inhibited by 4-AP. The pulmonary dilator effect of sevoflurane was not significantly affected by any of the K + channel inhibitors (Figure 2 ). D Di is sc cu us ss si io on n The effect of anesthetics on pulmonary vessels was investigated in the presence of three subtypes of potassium channel inhibitors. Despite the presence of several subtypes of K V channels in the pulmonary vessels, 6 the 4-AP-sensitive K V channel was investigated in the present study. The results clearly indicate that both 4-AP-sensitive K V channels and K Ca channels regulate basal pulmonary arterial tone. The vasodilation of cerebral 7 and mesenteric vessels 8 induced by isoflurane and sevoflurane appears to be mediated via the activation of K ATP channels. In the present study, however, the effect of volatile anesthetics on pulmonary vascular tension was not affected by K ATP channel inhibition. It is therefore likely that volatile anesthetics did not affect basal vascular tension through K ATP channels in the pulmonary vessels.
Although K V channels in mesenteric vessels are not affected by isoflurane, 8 4-AP-sensitive K V channels are suppressed reversibly by clinically relevant concentrations of halothane and isoflurane in canine coronary arteries. 9 The results of the present study suggest that halothane, enflurane and isoflurane may regulate pulmonary vascular tension through K V channels. Data are mean ± SD; n = 7. *P < 0.05 vs the value before inhalation; #P < 0.01 vs the value before inhalation. Ppa (mmHg) = pulmonary artery pressure; Ppv (mmHg) = pulmonary venous pressure; Pdo = double occlusion pressure; flow (mL·min -1 ) = perfusion flow; Rt (mmHg·L -1 ·min -1 ) = total pulmonary vascular resistance; Ra (mmHg·L -1 ·min -1 ) = pulmonary artery resistance; Rv (mmHg·L -1 ·min -1 ) = pulmonary venous resistance. Data are mean ± SD; n = 7. *P < 0.05 vs the value before inhalation; #P < 0.01 vs the value before inhalation.; 4-AP = 4-aminopyridine; IbTX = iberitoxin; Glib = glibenclamide.
Enflurane and halothane may inhibit K V channels or strengthen the inhibitory effect of channel inhibitors. Volatile anesthetics affect K Ca channels in aortic endothelial cells 10 and small mesenteric arteries. 8 Our results suggest that halothane may also have significant effects on K Ca channels in pulmonary vessels. Since the constrictive effect of halothane on pulmonary vessels was attenuated by IbTX, it is likely that halothane may activate K Ca channels, and consequently hyperpolarize the membrane potential of smooth muscle cells.
In summary, pulmonary vascular effects vary between volatile anesthetics. Halothane constricted pulmonary vessels, and the constrictive effect was potentiated by K V channel inhibition (4-AP), attenuated by K Ca channel inhibition (IbTX), but not altered by K ATP channel inhibition (Glib). Enflurane constricted pulmonary vessels, and the constrictive effect was potentiated by K V channel inhibition, but not changed by K Ca or K ATP channel inhibition. Isoflurane, neither a vasoconstrictor nor dilator, constricted pulmonary vessels when K V channels were inhibited with 4-AP. Sevoflurane dilated pulmonary vessels, and dilation was not influenced by any K + channel subtype inhibitor in isolated rabbit lungs. The results suggest that halothane, enflurane, and isoflurane (but not sevoflurane) regulate pulmonary vascular tension through K V and/or K Ca channels in isolated rabbit lungs.
A Ac ck kn no ow wl le ed dg ge em me en nt t The authors thank Jason Keller for English grammar editing assistance. FIGURE 2 Total pulmonary vascular resistance (Rt) before and after anesthetic inhalation. See text for details. Data are mean ± SD. n = 7 per group. *P < 0.01 vs control group. Rt difference = resistance after anesthetic administration -(minus) resistance before anesthetic administration.
